Table 1 Frequencies of used oral contraceptive compounds.
From: Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives
Active Ingredient | Dosage (mg) | N | % | ||
|---|---|---|---|---|---|
Single Compound | |||||
Medroxyprogesteron | 92.69 | 1 | 1.35 | ||
Desogestrel | 0.075 | 3 | 4.05 | ||
Combined Compound | |||||
Monophasic | |||||
Ethinylestradiol | Levonorgetrel | 0.02 | 0.1 | 4 | 5.41 |
0.03 | 0.125 | 8 | 10.81 | ||
0.03 | 0.15 | 4 | 5.41 | ||
0.05 | 0.125 | 2 | 2.7 | ||
Desogestrel | 0.02 | 0.15 | 2 | 2.7 | |
0.03 | 0.15 | 10 | 13.51 | ||
Norgestimat | 0.035 | 0.25 | 3 | 4.05 | |
Drespirenon | 0.02 | 3 | 4 | 5.41 | |
0.03 | 3 | 3 | 4.05 | ||
Chlormadinon | 0.03 | 1.79 | 3 | 4.05 | |
Dienogest | 0.03 | 2 | 15 | 20.27 | |
Triphasic | |||||
Ethinylestradiol | Levonorgetrel | 0.03 | 0.125 | 2 | 2.7 |
0.04 | 0.075 | ||||
0.03 | 0.05 | ||||
0.03 | 0.125 | 8 | 10.81 | ||
0.03 | 0.05 | ||||
0.04 | 0.075 | ||||
0.03 | 0.05 | 1 | 1.35 | ||
0.03 | 0.125 | ||||
0.04 | 0.075 | ||||
Ethinylestradiol | Desogestral | 0.03 | 0.1 | 1 | 1.35 |
0.03 | 0.15 | ||||
0.035 | 0.05 | ||||
